EUVIMED · CrossrefJournal
Trends in Molecular Medicine
ISSN 1471-4914 · Elsevier BV
Latest articles
Is endometriosis a progressive disease?
Muscle-to-CNS signaling in physiological homeostasis, aging, and disease
Targeting the hyaluronic acid–CD44 axis in hepatocellular carcinoma
Mitochondrial dysfunction in cerebrovascular diseases
Targeting the NAD+–PARP1–XRCC1 axis in ALS
Ubiquitin-specific peptidase 22 targeting: Tumor cell erasure, immune engine unleashed
Plasma signals reveal targetable tumor-promoting lung niches
Formicitoxins: membrane-targeting antifungal peptides from carpenter ant venoms
Mesoscale tissue states in fibrosis: from pathway targeting to state-directed therapy
Beyond the skin: how skin-derived signals shape systemic immunity
Trends at 50: a mission that matters
When antioxidant proteins become extracellular immune signals
Advisory Board and Contents
Subscription and Copyright Information
Vascular-device Suitcordance: a tri-ecological framework for eco-rebalancing
Harnessing the lung microbiome for precision management of fibrotic lung disease
Genomic newborn screening, a healthcare system transformation
Cholesterol metabolism: a new checkpoint in cancer immunity
Cellular reprogramming beyond pluripotency
Decoding GPX4 regulation in ferroptosis: mechanisms and therapeutic implications
Converging signalling disruptions: a threshold for Down syndrome hearts
Lipodystrophy syndromes: when the absence of adipose tissue rewires whole-body metabolism
Hyocholic acids: Third bile acids for neonatal health
Scleroderma: disease subtypes and multiorgan manifestations
RNA translational control in skeletal development, homeostasis, and disease
The role of pharmacomicrobiomics in colorectal cancer therapy
The niche–metabolism axis: reprogramming tumor-associated macrophages for precision immunotherapy
Tumor metaboception: local PGE2 signals global decline
Emerging therapeutic opportunities targeting nonclassical MHC-I molecules
Advisory Board and Contents
EUVIMED